Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1. (Q43687828)
scientific article published in August 2001
Language:
(P31) (Q13442814)
(P50) (Q13855780)
(Q88380300)
(Q124236631)
(Q124249485)
(P304) 1735-1740
(P407) (Q1860)
(P433) 8
(P478) 50
(P577) Wednesday, August 1, 2001
(P921) (Q124407)
(Q785022)
(Q79460)
(P1433) (Q895262)
(P1476) "Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1." (language: en)
(P2093) L Yu
D D Cuthbertson
R Jackson
T Orban
DPT-1 Participating Investigators
other details
description scientific article published in August 2001

External Links